ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 34

The Impact of Cardiovascular and Lung Disorder Morbidities on Physical Activity in People with Inflammatory Arthritis Compared to the General Population in the UK

Michael Cook1, Eftychia Bellou2, Jamie C Sergeant3, John Bowes2, Anne Barton4, Terence W. O'Neill1 and Suzanne M.M. Verstappen1, 1Arthritis Research UK Centre for Epidemiology, The University of Manchester, Centre for Musculoskeletal Research, Manchester, United Kingdom, 2Arthritis Research UK Centre for Genetics and Genomics, The University of Manchester, Centre for Musculoskeletal Research, Manchester, United Kingdom, 3NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom, 4NIHR Manchester Musculoskeletal Biomedical Research Unit, Manchester Academic Health Science Centre, Manchester, United Kingdom

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: inflammatory arthritis, physical activity and population studies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Epidemiology and Public Health Poster I: Comorbidities and Outcomes of Systemic Inflammatory Diseases

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Cardiovascular and lung disorder morbidities are more common in people with inflammatory arthritis (IA) than in the general population.  However, little is known about the impact of these morbidities on daily functioning including physical activity.  The aim of this study was to investigate the levels of physical activity in people with and without these morbidities.

Methods:    This study was conducted in a large population-based study in the UK (UK Biobank), including people aged 40 to 70.   Age, gender, and smoking status were recorded at inclusion.  Inflammatory arthritis (rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS)) and morbidity data including cardiovascular diseases (heart attack, angina, stroke) and lung disorders (emphysema, bronchitis, and asthma) was identified on the basis of self-report and participants were categorised as follows:  no IA and no morbidity (noIA-noM), no IA and morbidity (noIA-M), IA and no morbidity (IA-noM) or IA and morbidity (IA-M).   Participants completed the International Physical Activity Questionnaire and were classified as doing “low physical activity (lpa)”, “moderate physical activity (mpa)” or “vigorous physical activity (vpa)”.  Multinominal logistic regression analysis was applied to assess the association between health status group (noIA-noM=base case) and physical activity group (lpa=reference), adjusted for gender, age and smoking, and presented as relative risk ratios (adjRRR, (95%CI)).  Adjusted probabilities for each activity level are presented in figure.

Results: This study included 400,261 (81.5%) people with noIA-noM, 83,246 (17.0%) people with noIA-M, 5,800 (1.2%) people with IA-noM, and 1,790 (0.36%) people with IA-M.  Percentage female gender was, respectively, 55%, 51%, 63%; and 63% and mean (SD) age ranged from 56 (8) to 59 (7) years.  Within each group, the percentage of participants doing lpa, mpa or vpa was, respectively:  lpa (24.9%, 29.3%, 34.9%, 42.9%); mpa (38.4%, 36.9%, 35.6%, 32.0%) or vpa (36.7%, 33.8%, 29.5%, 25.1%).  The expected risk for people with a cardiovascular/lung disorder morbidity and/or IA doing moderate or vigorous activity was lower than those without these diseases.  Furthermore, people with IA, but no morbidity, were less likely to do mpa or vpa than people without IA, but having these morbidities.  adjRRRs (95%CI) for noIA-M, IA-noM and IA-M were respectively:  for mpa (0.82 (0.80-0.83); 0.66 (0.62-0.71); 0.49 (0.44-0.55)) and even lower for vpa (0.78 (0.77-0.79); 0.59 (0.55-0.63); 0.42 (0.37-0.47)).  Adjusted probabilities are shown in figure.

Conclusion:  In this large population-based study we observed that people with both IA and morbidities were less active compared to those without morbidities or those with no IA and morbidities.  It is therefore important to evaluate morbidities in clinical studies when investigating functional ability.

graph2.png


Disclosure: M. Cook, None; E. Bellou, None; J. C. Sergeant, None; J. Bowes, None; A. Barton, None; T. W. O'Neill, None; S. M. M. Verstappen, None.

To cite this abstract in AMA style:

Cook M, Bellou E, Sergeant JC, Bowes J, Barton A, O'Neill TW, Verstappen SMM. The Impact of Cardiovascular and Lung Disorder Morbidities on Physical Activity in People with Inflammatory Arthritis Compared to the General Population in the UK [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-impact-of-cardiovascular-and-lung-disorder-morbidities-on-physical-activity-in-people-with-inflammatory-arthritis-compared-to-the-general-population-in-the-uk/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-impact-of-cardiovascular-and-lung-disorder-morbidities-on-physical-activity-in-people-with-inflammatory-arthritis-compared-to-the-general-population-in-the-uk/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology